Brompton Funds: Global Healthcare Income & Growth ETF

September 15, 2022

The world’s healthcare needs are changing and growing. Global Healthcare Income & Growth ETF; active management and high distributions.

This ETF provides monthly distributions and the opportunity for capital gains through an investment in a portfolio of large-cap global Healthcare companies selected by Brompton, complemented by an actively managed covered call program.

Its PM team first uses a top-down analysis to identify attractive sub-sectors. Rigorous fundamental analysis focuses the portfolio on 15 to 30 global Healthcare companies which offer a combination of growth and value characteristics. The PMs then set the level of covered call writing (up to a maximum of 33%), with the goal of optimizing distributable cash and total returns.

Why Invest In Healthcare?

  • Strong historical earnings growth and stable relative share performance.
  • Under-represented sector in the Canadian equity market; global Healthcare equities provide diversification benefits.

Long term trends are supportive of Healthcare equities:

  • Demographics: Aging world population is expected to result in increased demand for healthcare products and services
  • Emerging Markets: Rising incomes should lead to higher healthcare spending
  • Innovation: Opening up new frontiers for development of services, equipment and therapies
  • Mergers & Acquisitions: Providing the potential for added value for investors

For more information on Brompton Funds Ltd. (TSX: HIG) please fill out the form below.

Detailed Quote

Invalid Symbol: HIG:CA

You might also like

Healthcare
Gain Therapeutics: Targeting Parkinson’s at the Cellular Level

Gain Therapeutics is advancing an experimental therapy designed to repair damaged brain cells in Parkinson’s disease, bringing new hope to patients and families.

Healthcare
Gain Therapeutics: Advancing Science in the Fight Against Parkinson’s

Gain Therapeutics is researching innovative therapies that aim to address Parkinson’s disease at its source—not just the symptoms.

Content Broadcast on: BNN Bloomberg, CNBC, FOX Business News, BIZTV, Reuters, The Globe and Mail, YouTube and more!